A phase 1 trial of PfCP2.9: an AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria.

Source:http://linkedlifedata.com/resource/pubmed/id/18930094

Vaccine 2008 Dec 9 26 52 6864-73

Download in:

View as

Triples

General Info

PMID
18930094